4.8 Article

C9orf72-derived arginine-rich poly-dipeptides impede phase modifiers

期刊

NATURE COMMUNICATIONS
卷 12, 期 1, 页码 -

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41467-021-25560-0

关键词

-

资金

  1. AMED [JP20dm0307032, JP21wm0425004, JP21ek0109437, JP21ek0109558]
  2. JSPS KAKENHI [JP17H07031, JP18H06202, JP19K21306, JP20K16583, JP19H04945, JP19K06504, JP17H05657, JP17H05867, JP20KK0156, JP20H03199, JP19H05769, JP19K16060, JP20K06493, JP19K16088, JP21K15051, JP19KK0071, JP20K06579, JP18H05229, JP18H05534, JP18H03681, JP20K06527, JP20H00327, JP21K06031, JP18H02391, JP20H05925, JP21H04763, JP18K06094, JP19K23976, JP19K17043, JP21K15032, JP19K17044, JP19K07978]
  3. JST FOREST Program [JPMJFR204W]
  4. JST CREST Program [JPMJCR1762]
  5. Cooperative Research Project Program of Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA Center), University of Tsukuba, Japan [181107, 201904, 202007]
  6. Joint Research Programs, the Institute of Advanced Medical Sciences, Tokushima University
  7. Takeda Science Foundation
  8. Kanzawa Medical Research Foundation
  9. Uehara Memorial Foundation
  10. Nakatomi Foundation
  11. Konica Minolta Science and Technology Foundation
  12. Naito Foundation
  13. MSD Life Science Foundation
  14. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  15. SENSHIN Medical Research Foundation
  16. Terumo Foundation for Life Sciences and Arts
  17. Nara Kidney Disease Research Foundation
  18. Novartis Research Grants
  19. Nara Medical University
  20. Akiyama Life Science Foundation
  21. Northern Advancement Center for Science and Technology
  22. Sumitomo Foundation
  23. Astellas Foundation for Research on Metabolic Disorders
  24. Senri Life Science Foundation
  25. Nakajima Foundation
  26. Asahi Glass Foundation
  27. Daiichi Sankyo Foundation of Life Science
  28. Nakabayashi Trust
  29. Integrated Research Consortium on Chemical Sciences
  30. Izumi Science and Technology Foundation
  31. Tokyo Biochemical Research Foundation
  32. project for Construction of the basis for the advanced materials science and analytical study by the innovative use of quantum beam and nuclear sciences in KURNS

向作者/读者索取更多资源

This study demonstrates how arginine-rich poly-dipeptides hinder the function of nuclear import receptors (NIRs) in modifying the phase transitions of RNA-binding proteins (RBPs), leading to neurodegeneration associated with C9orf72.
Nuclear import receptors (NIRs) regulate self-association of RNA-binding proteins as phase modifiers, while C9orf72-derived arginine-rich polydipeptides lead to aberrant phase transitions. Here the authors show in molecular basis how arginine-rich poly-dipeptides impede the ability of NIRs, particularly Kap beta 2. Nuclear import receptors (NIRs) not only transport RNA-binding proteins (RBPs) but also modify phase transitions of RBPs by recognizing nuclear localization signals (NLSs). Toxic arginine-rich poly-dipeptides from C9orf72 interact with NIRs and cause nucleocytoplasmic transport deficit. However, the molecular basis for the toxicity of arginine-rich poly-dipeptides toward NIRs function as phase modifiers of RBPs remains unidentified. Here we show that arginine-rich poly-dipeptides impede the ability of NIRs to modify phase transitions of RBPs. Isothermal titration calorimetry and size-exclusion chromatography revealed that proline:arginine (PR) poly-dipeptides tightly bind karyopherin-beta 2 (Kap beta 2) at 1:1 ratio. The nuclear magnetic resonances of Kap beta 2 perturbed by PR poly-dipeptides partially overlapped with those perturbed by the designed NLS peptide, suggesting that PR poly-dipeptides target the NLS binding site of Kap beta 2. The findings offer mechanistic insights into how phase transitions of RBPs are disabled in C9orf72-related neurodegeneration.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据